These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3984379)
1. Intra- and inter-species comparisons of biliary metabolic profiles of butoprozine by high performance liquid chromatography. Overzet F; de Zeeuw RA Xenobiotica; 1985 Jan; 15(1):1-10. PubMed ID: 3984379 [TBL] [Abstract][Full Text] [Related]
2. Multichannel diode array UV-visible spectrophotometer as detector in screening for unknown butoprozine metabolites in dog bile by high-performance liquid chromatography. Overzet F; Ghijsen RT; Drenth BF; De Zeeuw RA J Chromatogr; 1982 May; 240(1):190-5. PubMed ID: 7096514 [No Abstract] [Full Text] [Related]
3. High-performance liquid chromatography in the elucidation of the metabolic fate of butoprozine: screening for unknown metabolites in the rat. Drenth BF; de Zeeuw RA J Chromatogr; 1980 Apr; 191():109-14. PubMed ID: 7380960 [TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic isolation and fast atom bombardment mass spectrometric identification of Di-N-desethylamiodarone, a new metabolite of amiodarone in the dog. Latini R; Reginato R; Burlingame AL; Kates RE Biomed Mass Spectrom; 1984 Sep; 11(9):466-71. PubMed ID: 6509156 [TBL] [Abstract][Full Text] [Related]
5. On-line diode array UV-visible spectrometry in screening for drugs and drug metabolites by high-performance liquid chromatography. Overzet F; Rurak A; van der Voet H; Drenth BF; Ghijsen RT; de Zeeuw RA J Chromatogr; 1983 Sep; 267(2):329-45. PubMed ID: 6630371 [TBL] [Abstract][Full Text] [Related]
6. Identification of amiodarone metabolites in human bile by ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry. Deng P; You T; Chen X; Yuan T; Huang H; Zhong D Drug Metab Dispos; 2011 Jun; 39(6):1058-69. PubMed ID: 21398391 [TBL] [Abstract][Full Text] [Related]
7. Characterization of amiodarone metabolites and impurities using liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. Myung SW; Chang YJ; Min HK; Kim DH; Kim M; Kang TK; Yoo EA; Sohn YT; Yim YH Rapid Commun Mass Spectrom; 2000; 14(21):2046-54. PubMed ID: 11085417 [TBL] [Abstract][Full Text] [Related]
8. Identification and measurement of desethylamiodarone in blood plasma specimens from amiodarone-treated patients. Flanagan RJ; Storey GC; Holt DW; Farmer PB J Pharm Pharmacol; 1982 Oct; 34(10):638-43. PubMed ID: 6128385 [TBL] [Abstract][Full Text] [Related]
9. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog. Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of amiodarone metabolites in rats using UPLC-ESI-QTOFMS-based untargeted metabolomics approach. Jeong ES; Kim G; Yim D; Moon KS; Lee SJ; Shin JG; Kim DH J Toxicol Environ Health A; 2018; 81(12):481-492. PubMed ID: 29641932 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of dronedarone and its active metabolite debutyldronedarone in human plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study. Xie C; Yang S; Zhong D; Dai X; Chen X J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(28):3071-5. PubMed ID: 21937291 [TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro metabolism studies on a class III antiarrhythmic agent. Vickers S; Duncan CA; Kari PH; Homnick CF; Elliott JM; Pitzenberger SM; Hichens M; Vyas KP Drug Metab Dispos; 1993; 21(3):467-73. PubMed ID: 8100503 [TBL] [Abstract][Full Text] [Related]
14. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans. Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiological effects of butoprozine on isolated heart preparations. Comparison with amiodarone and verapamil. Néliat G; Moreau M; Ducouret P; Gargouïl YM Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):220-36. PubMed ID: 6978694 [TBL] [Abstract][Full Text] [Related]
16. Screening for impurities in butoprozine. Drenth BF; Jagersma T; Wormeester AJ; de Zeeuw RA Pharm Weekbl Sci; 1983 Aug; 5(4):149-52. PubMed ID: 6622208 [TBL] [Abstract][Full Text] [Related]
17. Metabolic disposition of enciprazine, a non-benzodiazepine anxiolytic drug, in rat, dog and man. Scatina JA; Lockhead SR; Cayen MN; Sisenwine SF Xenobiotica; 1991 Dec; 21(12):1591-604. PubMed ID: 1686125 [TBL] [Abstract][Full Text] [Related]
18. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits. Kannan R; Miller S; Singh BN Drug Metab Dispos; 1985; 13(6):646-50. PubMed ID: 2867865 [TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric identification of amiodarone N-monodesethyl metabolite and application of an HPLC method to a pharmacokinetic study. Marchiset D; Aubert C; Sumirtapura YC; Egre A; Cano JP Eur J Drug Metab Pharmacokinet; 1984; 9(2):123-8. PubMed ID: 6745303 [TBL] [Abstract][Full Text] [Related]
20. Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection. Bolderman RW; Hermans JJ; Maessen JG J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(18-19):1727-31. PubMed ID: 19427276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]